Cargando…

Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics

Shenmai injection (SMI) is a well-defined herbal preparation that is widely and clinically used as an adjuvant therapy for cancer. Previously, we found that SMI synergistically enhanced the activity of chemotherapy on colorectal cancer by promoting the distribution of drugs in xenograft tumors. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Chongjin, Jiang, Chao, Ni, Suiying, Wang, Qizhi, Cheng, Lingge, Wang, Huan, Zhang, Qixiang, Liu, Wenyue, Zhang, Jingwei, Liu, Jiali, Wang, Mulan, Jin, Min, Shen, Peiqiang, Yao, Xuequan, Wang, Guangji, Zhou, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564034/ https://www.ncbi.nlm.nih.gov/pubmed/33088689 http://dx.doi.org/10.1016/j.apsb.2019.12.011

Ejemplares similares

Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway
por: Liu, Wenyue, et al.
Publicado: (2018)

Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
por: Shan, Yunlong, et al.
Publicado: (2022)

Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes
por: YE, LI-FANG, et al.
Publicado: (2015)

An Overview of Systematic Reviews of Shenmai Injection for Healthcare
por: Lu, Ling-yan, et al.
Publicado: (2014)

Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats
por: Zhou, Qian, et al.
Publicado: (2017)

Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice
por: Liu, Jiali, et al.
Publicado: (2015)

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023)

Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting
por: Yang, Geng, et al.
Publicado: (2023)

Therapeutic efficacy of shenmai injection as an adjuvant treatment in dilated cardiomyopathy: A protocol for systematic review
por: Gao, Kai, et al.
Publicado: (2020)

Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
por: Li, Lin, et al.
Publicado: (2020)

Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
por: Wang, Shao-mei, et al.
Publicado: (2020)

Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction
por: Zheng, Zhaohai, et al.
Publicado: (2022)

Adjuvant Application of Shenmai Injection for Sepsis: A Systematic Review and Meta-Analysis
por: Sun, Ye, et al.
Publicado: (2022)

The Neuroprotective Effect of Shenmai Injection on Oxidative Stress Injury in PC12 Cells Based on Network Pharmacology
por: Wu, Jing, et al.
Publicado: (2022)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Comparison of Protective Effects of Shenmai Injections Produced by Medicinal Materials from Different Origins on Cardiomyocytes
por: Zhao, Min, et al.
Publicado: (2022)

Shenmai-Yin decreased the clearance of nifedipine in rats: The involvement of time-dependent inhibition of nifedipine oxidation
por: Wang, Hong-Jaan, et al.
Publicado: (2018)

Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review
por: Gao, Peng, et al.
Publicado: (2020)

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
por: Zhang, Shiyu, et al.
Publicado: (2022)

Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics
por: Zhang, Jingwei, et al.
Publicado: (2012)

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019)

Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation
por: Hou, Xianbing, et al.
Publicado: (2023)

Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
por: Hong, Xiaodan, et al.
Publicado: (2022)

Effect of Shenmai injection on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial
por: Chen, Lei, et al.
Publicado: (2018)

Target-responsive subcellular catabolism analysis for early-stage antibody–drug conjugates screening and assessment
por: Sang, Hua, et al.
Publicado: (2021)

The clinical efficacy of Shenmai injection in the prophylaxis and treatment of intradialytic hypotension: A protocol for systematic review and meta-analysis
por: Xiang, Zhen, et al.
Publicado: (2022)

The effect of Shenmai injection on the proliferation of Rat airway smooth muscle cells in asthma and underlying mechanism
por: Zhao, Limin, et al.
Publicado: (2013)

Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps
por: Liu, Xiaopei, et al.
Publicado: (2018)

Ginsenoside Rh2 pretreatment and withdrawal reactivated the pentose phosphate pathway to ameliorate intracellular redox disturbance and promoted intratumoral penetration of adriamycin
por: Liu, Jiali, et al.
Publicado: (2020)

Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a
por: Li, Yanyang, et al.
Publicado: (2023)

Authentication and distinction of Shenmai injection with HPLC fingerprint analysis assisted by pattern recognition techniques
por: Lu, Xue-Feng, et al.
Publicado: (2012)

Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein
por: Liang, Yan, et al.
Publicado: (2014)

The immediate adverse drug reactions induced by ShenMai Injection are mediated by thymus-derived T cells and associated with RhoA/ROCK signaling pathway
por: Jiang, Shan, et al.
Publicado: (2023)

Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction
por: Wang, Wenjie, et al.
Publicado: (2017)

Effects of Shenmai injection on the values of CO, SV, and EF in patients undergoing off-pump coronary artery bypass graft: A randomized, clinical trial
por: Liu, Qingxue, et al.
Publicado: (2018)

Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549/DDP cells
por: Chen, Yushi, et al.
Publicado: (2021)

The Inhibition Effects of Shenmai Injection on Acetylcholine-Induced Catecholamine Synthesis and Secretion by Modulating Nicotinic Acetylcholine Receptor Ion Channels in Cultured Bovine Adrenal Medullary Cells
por: Zhang, Xiting, et al.
Publicado: (2020)

Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis
por: Qin, Guo-wei, et al.
Publicado: (2021)

Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification
por: He, Yanqiu, et al.
Publicado: (2022)

Efficacy Evaluation of the Mahuang-Fuzi-Xixin Decoction in Combination with Shenmai Injection for Bradyarrhythmia Treatment: A Systematic Review and Meta-Analysis
por: Zhang, Zhang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r4hf6ahubsvdsrkkb4s15ov80a